Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.

Pharmaceutical

Cipla

Umang Vohra

The executive team at Cipla has a lot of experience in the field, with members coming from companies such as Dr. Reddy's Laboratories and Pepsico- India. They also have a variety of educational backgrounds, including Management and Computer Science from T.A. PAI MANAGEMENT INSTITUTE and MSRIT, Bangalore respectively.

CEO and Executive Team

About

Team members

Other teams at Cipla

Board of Directors

Leadership Team